45226 Federal Register / Vol. 73, No. 150 / Monday, August 4, 2008 / Notices 

well as their knowledge, attitudes, and 

behaviors related to preventive cancer 

screenings. Of particular interest are 

adults of various races and ethnicities 

who are at high risk for lung cancer (i.e., 

long-term heavy smokers). 

The proposed project will use focus 

groups to gather information about the 

target audiences’ experiences and 

practices related to lung cancer 

screening and testing. If warranted from 

focus group data with adult consumers, 

follow-up personal interviews will be 

conducted with selected focus group 

participants, especially those reporting 

experience with screening tests, such as 

spiral computed tomography (CT). 

A total of 16 focus groups will be 

conducted at professional focus group 

facilities with long-term heavy smokers 

ages 40–70. The data will be collected 

from a convenience sample of adults 

who will be screened and recruited 

using lists maintained by the focus 

group facilities. Each focus group will 

include approximately nine participants 

and last two hours. If warranted, 

additional in-depth interviews will be 

conducted with up to 16 focus group 

participants. 

Eight telephone focus groups will be 

conducted with a random sample of 

primary care physicians recruited from 

the American Medical Association 

Physician Masterfile list. Potential 

physician respondents will be mailed a 

screening packet to complete and 

return. Each focus group of physicians 

will include approximately six 

participants and last 75 minutes. Two 

alternates will be recruited for each 

physician focus group in order to ensure 

participation of the targeted number of 

respondents. 

Information will be collected over the 

two-year project period. There are no 

costs to respondents except their time. 

The total estimated annualized burden 

hours are 198. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of 

respondents Form name Number of respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total 

burden 

(in hours) 

Health Care Consumers .......................... Health Care Consumer Screener Form .. 144 1 2/60 5 

Moderator’s Guide for Health Care Consumer Focus Groups.72 1 2 144 

Guide for In-Depth Interviews with 

Health Care Consumers.

8 1 1 8 

Physicians ................................................ Physician Response Form ...................... 64 1 5/60 5 

Moderator’s Guide for Physician Focus 

Groups.

24 1 1 .5 36 

Total .................................................. .................................................................. .................... .................... ...................... 198 

Marilyn S. Radke, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E8–17772 Filed 8–1–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day-80–08BL] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Maryam I. Daneshvar, 

CDC Acting Reports Clearance Officer, 

1600 Clifton Road, MS–D74, Atlanta, 

GA 30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Rapid HIV Testing in Community 

Mental Health Settings Serving African 

Americans—New—National Center for 

HIV, Viral Hepatitis, STD and TB 

Prevention (NCHHSTP), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

People with chronic mental illness, 

including those with substance use 

disorders, are at increased risk of HIV 

compared with the general population. 

However, not enough is known about 

the risk behaviors, willingness to be 

tested for HIV and HIV prevalence 

among persons with chronic mental 

illness. In addition, the interrelations 

among diagnosis of HIV infection, 

compliance with medical care, 

subsequent risk behaviors, and the 

course of mental illness have not been 

well-described. Mental health clinics 

are an important setting for HIV rapid 

testing and promoting prevention efforts 

against the transmission of HIV 

infection. 

The objectives of this project are to (1) 

demonstrate improved access to HIV 

testing and linkage to care in 

participating mental health care 

settings; and (2) describe the 

relationship between mental illness, 

HIV risk behaviors, and access to testing 

and services, in order to inform the 

development of optimal prevention 

interventions for persons with severe 

mental illness. Staff at selected 

implementation sites will offer testing 

for HIV to clients and administer a brief 

survey to assess risk behaviors, previous 

access to similar testing services, and 

mental health symptoms. 

CDC is requesting approval for a 2- 

year clearance for data collection. Data 


pwalker on PROD1PC71 with NOTICES
Federal Register / Vol. 73, No. 150 / Monday, August 4, 2008 / Notices 45227 

will be collected in 6 community mental 

health sites. This project will collect 

data from clients using a brief survey 

administered on a voluntary basis. 

Collection of data will provide 

information on client demographics; 

current behaviors that may facilitate 

HIV transmission, including sexual and 

drug-use behaviors; current psychiatric 

symptoms, determined using brief rating 

scales; access and barriers to HIV 

testing, prevention, and treatment 

services; and adherence to psychiatric 

and medical treatment regimens. 

CDC estimates the response rate will 

be approximately 90%. Of the 644 

persons approached who agree to be 

surveyed, it is estimated that 95% of 

persons will meet the eligibility criteria 

and 98% will be able to provide 

informed consent. Therefore, the goal 

will be to approach 716 persons 

annually for participation in the study. 

The structured interview will take 

approximately 20 minutes to complete. 

Participation is voluntary. Data 

collection will provide important 

insights into the relationship between 

HIV/STI risk behaviors and psychiatric 

illness. 

There is no cost to the respondents 

other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name No. of respondents 

No. of responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden hours 

Approached Individual .............................. Eligibility Screener .................................... 644 1 1/60 11 

Eligible participant ..................................... Consent Questionnaire ............................. 612 1 10/60 102 

Consented participant ............................... Core Questionnaire .................................. 600 1 20/60 200 

Total ................................................... ................................................................... .................... .................... .................... 313 

Marilyn S. Radke, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E8–17775 Filed 8–1–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Notice of Public Comment on Tribal 

Consultation Session To Be Held on 

September 11, 2008, in Phoenix, AZ 

AGENCY: Office of Head Start (OHS). 

ACTION: Notice of Public Comment on 

Tribal Consultation Session to be held 

on September 11, 2008, in Phoenix, 

Arizona. 

SUMMARY: Pursuant to the Improving 

Head Start for School Readiness Act of 

2007, Public Law 110–134, notice is 

hereby given of a one-day Tribal 

Consultation Session to be held between 

the Department of Health and Human 

Services, Administration for Children 

and Families, Office of Head Start 

leadership and the leadership of Tribal 

governments operating Head Start 

(including Early Head Start) programs. 

The purpose of the Consultation Session 

is to discuss ways to better meet the 

needs of Indian, including Alaska 

Native, children and their families, 

taking into consideration funding 

allocations, distribution formulas, and 

other issues affecting the delivery of 

Head Start services in their geographic 

locations [42 U.S.C. 9835, Section 

640(l)(4)]. 

Date & Location: The Consultation 

Session will be held on September 11, 

2008, at the Hyatt Regency Phoenix in 

Phoenix, Arizona. 

FOR FURTHER INFORMATION CONTACT: 

Rene ́e Perthuis, Acting Regional 

Program Manager, American Indian/ 

Alaska Native Program Branch, Office of 

Head Start, e-mail 

reneeaian@acf.hhs.gov or (202) 260–

1721. Register to attend the Consultation 

Session online at www.hsnrc.org. 

SUPPLEMENTARY INFORMATION: The 

Department of Health and Human 

Services would like to invite leaders of 

Tribal governments operating Head Start 

(including Early Head Start) programs to 

participate in a formal Consultation 

Session with OHS leadership. The 

Consultation Session will take place on 

Thursday, September 11, 2008, at the 

Hyatt Regency Phoenix in Phoenix, 

Arizona. 

The purpose of the Consultation 

Session is to solicit input on ways to 

better meet the needs of Indian, 

including Alaska Native, children and 

their families, taking into consideration 

funding allocations, distribution 

formulas, and other issues affecting the 

delivery of Head Start services in their 

geographic locations. Specific topics 

will include policy, research, Head 

Start/Early Head Start conversion, 

program quality, and monitoring. 

Tribal leaders and designated 

representatives interested in submitting 

written testimony or topics for the 

Consultation Session agenda should 

contact Rene ́e Perthuis at 

reneeaian@acf.hhs.gov. The proposal 

agenda topics should include a brief 

description of the topic area along with 

the name and contact information of the 

suggested presenter. 

The Consultation Session will be 

conducted with elected or appointed 

leaders of Tribal governments and their 

designated representatives [42 U.S.C. 

9835, Section 640(l)(4)(A)]. 

Representatives from Tribal 

organizations and Native non-profit 

organizations are welcome to attend as 

observers. Those wishing to participate 

in the discussions must have a copy of 

a letter signed by an elected or 

appointed official or their designee, 

which authorizes them to serve as a 

representative of the Tribe. This should 

be submitted not less than three days in 

advance of the Consultation Session to 

Rene ́e Perthuis at 202–205–9721 (fax). 

A detailed report of the Consultation 

Session will be prepared and made 

available within 90 days of the 

consultation to all Tribal governments 

receiving funds for Head Start 

(including Early Head Start) programs. 

Dated: July 29, 2008. 

Patricia Brown, 

Acting Director, Office of Head Start. 

[FR Doc. E8–17774 Filed 8–1–08; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2008–D–0387] 

Draft Guidance for Industry on 

Labeling OTC Skin Protectant Drug 

Products; Availability 

AGENCY: Food and Drug Administration, 

HHS. 


pwalker on PROD1PC71 with NOTICES